Proposed Data Collection Submitted for Public Comment and Recommendations, 32185-32187 [2019-14301]
Download as PDF
<![CDATA[
32185
Federal Register / Vol. 84, No. 129 / Friday, July 5, 2019 / Notices
7,500 ineligible screened persons during
a three-year period. Data collection will
rotate such that interviews will be
conducted among one group per year:
MSM in Year 1, IDU in Year 2, and HET
in Year 3. The type of data collected for
each group will vary slightly due to
different sampling methods and risk
characteristics of the group.
Participation of respondents is
voluntary and there is no cost to the
respondents other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)
Total burden
(in hours)
Form name
Persons Screened ............................
Eligible Participants ...........................
Eligible Participants ...........................
Eligible Participant ............................
Peer Recruiters .................................
Eligibility Screener ............................
Behavioral Assessment MSM ..........
Behavioral Assessment IDU ............
Behavioral Assessment HET ...........
Recruiter Debriefing .........................
15,000
4,167
4,167
4,167
4,167
1
1
1
1
1
5/60
24/60
43/60
31/60
2/60
1,250
1,667
2,986
2,153
139
Total ...........................................
...........................................................
........................
........................
........................
8,195
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2019–14305 Filed 7–3–19; 8:45 am]
BILLING CODE 4163–18–P
health system level changes to support
prevention and management of diabetes
and heart disease.
DATES: CDC must receive written
comments on or before September 3,
2019.
You may submit comments,
identified by Docket No. CDC–2019–
0055 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
ADDRESSES:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–19–19BHC; Docket No. CDC–19–
0055]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled EVALUATION OF THE DP18–
1815 COOPERATIVE AGREEMENT
PROGRAM: IMPROVING THE HEALTH
OF AMERICANS THROUGH
PREVENTION AND MANAGEMENT OF
DIABETES AND HEART DISEASE AND
STROKE. The purpose of data collection
is to determine CDC-funded recipients’
progress towards using DP18–1815
funds to implement evidence-based
strategies, and to determine how those
efforts are contributing to state level and
SUMMARY:
jbell on DSK3GLQ082PROD with NOTICES
Number of
responses per
respondent
Number of
respondents
Type of respondents
VerDate Sep<11>2014
17:54 Jul 03, 2019
Jkt 247001
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Evaluation of the DP18–1815
Cooperative Agreement Program:
Improving the Health of Americans
Through Prevention and Management of
Diabetes and Heart Disease and Stroke—
New—National Center for Chronic
Disease Prevention and Health
Promotion, Centers for Disease Control
and Prevention (CDC).
E:\FR\FM\05JYN1.SGM
05JYN1
32186
Federal Register / Vol. 84, No. 129 / Friday, July 5, 2019 / Notices
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC) Division of Diabetes
Translation (DDT) and Division for
Heart Disease and Stroke Prevention
(DHDSP) are submitting this new three
year information collection request
(ICR) for an evaluation of the recently
launched five-year Cooperative
Agreement program CDC–RFA–DP18–
1815PPHF18: Improving the Health of
Americans Through Prevention and
Management of Diabetes and Heart
Disease and Stroke, hereafter referred to
as ‘‘1815’’. This cooperative agreement
funds all 50 State Health Departments
and the Washington, DC health
department (hereafter referred to as ‘‘HD
recipients’’) to support investments in
implementing evidence-based strategies
to prevent and manage cardiovascular
disease (CVD) and diabetes in highburden populations/communities
within each state and the District of
Columbia. High burden populations/
communities are those affected
disproportionately by high blood
pressure, high blood cholesterol,
diabetes, or prediabetes due to
socioeconomic or other characteristics,
including access to care, poor quality of
care, or low income. The 1815 program
is a collaboration between DDT and
as well as select HD recipient partner
sites, which are organizations that HD
recipients are partnering with in the
implementation of the 1815 strategies.
The evaluation of cooperative
agreement strategies and activities
conducted by DDT and DHDSP will
determine the efficiency, effectiveness,
impact and sustainability of 1815funded strategies in the promotion,
prevention, and management of diabetes
and heart disease and help identify
promising practices that can be
replicated and scaled to better improve
health outcomes. In addition, evaluation
plays a critical role in organizational
learning, program planning, decisionmaking, and measurement of the 1815
strategies. As an action-oriented
process, the evaluation will serve to
identify programs that have positive
outcomes, identify those that may need
additional technical assistance support,
and highlight the specific activities that
make the biggest contribution to
improving diabetes and cardiovascular
disease prevention and management
efforts. Without collection of new
evaluative data, CDC will not be able to
capture critical information needed to
continuously improve programmatic
efforts and clearly demonstrate the use
of federal funds.
DHDSP and is structured into two
program categories aligning with each
Division: Category A focuses on diabetes
management and Type 2 diabetes
prevention; Category B focuses on CVD
prevention and management.
This cooperative agreement is a
substantial investment of federal funds.
DDT and DHDSP are responsible for the
stewardship of these funds, and they
must be able to demonstrate the types of
interventions being implemented and
what is being accomplished through the
use of these funds. Thus, throughout the
five-year cooperative agreement period,
CDC will work with HD recipients to
track the implementation of the
cooperative agreement strategies and
evaluate program processes and
outcomes. In order to collect this
information, CDC has designed four
overarching components: (1) Category A
rapid evaluation of DSMES and
National DPP partner sites, (2) Category
B case studies, (3) Category B cost study,
and (4) Category A and B recipient-led
evaluations. Each component consists of
data collection mechanisms and tools
that are designed to capture the most
relevant information needed to inform
the evaluation effort while placing
minimum burden on respondents.
Respondents will include HD recipients,
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Number of
respondents
Form name
Number of
responses per
respondent
Average
burden per
response
Total burden
(in hours)
Category A Site-Level Rapid Evaluation
HD recipient staff ..............................
HD recipient staff ..............................
DSMES partner site staff ..................
DSMES partner site staff ..................
DSMES partner site staff ..................
DSMES partner site staff ..................
National DPP partner site staff .........
National DPP partner site staff .........
jbell on DSK3GLQ082PROD with NOTICES
National DPP partner site staff .........
National DPP Partner Site-Level
Rapid Evaluation Site Nomination
Form.
DSMES Partner Site-Level Rapid
Evaluation Site Nomination Form.
DSMES Rapid Evaluation Interview
Guide—Program/Quality Coordinator.
DSMES Rapid Evaluation Interview
Guide—Paraprofessional.
DSMES Rapid Evaluation Interview
Guide—Health Professional.
DSMES Rapid Evaluation Survey
Questionnaire.
National DPP Rapid Evaluation
Interview Guide—Program Coordinator.
National DPP Rapid Evaluation
Interview Guide—Lifestyle Coach.
National DPP Rapid Evaluation Survey Questionnaire.
51
1
30/60
8.5
51
1
30/60
8.5
14
1
2
28
28
1
2
56
28
1
2
56
510
1
1
340
14
1
2
28
28
1
2
56
510
1
1
340
45
1
1.5
22.5
24
1
1.5
12
21
1
1.5
10.5
Category B Case Study—Site-Level Interviews
Partner site staff ................................
Partner site staff ................................
Partner site staff ................................
VerDate Sep<11>2014
17:54 Jul 03, 2019
CQM Partner Site-Level Interview
Guide.
TBC Partner Site-Level Interview
Guide.
MTM Partner Site-Level Interview
Guide.
Jkt 247001
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
E:\FR\FM\05JYN1.SGM
05JYN1
32187
Federal Register / Vol. 84, No. 129 / Friday, July 5, 2019 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
responses per
respondent
Number of
respondents
Type of respondents
Form name
Partner site staff ................................
CCL Partner Site-Level Interview
Guide.
45
Average
burden per
response
Total burden
(in hours)
1
1.5
22.5
1
1
1
1
2
2
2
2
33.5
17.5
16
33.5
40
1
2.5
67
40
1
2.5
67
40
1
2.5
67
25
1
2.5
21
50
1
2.5
42
Category B Case Study—SHD-Level Interview
HD
HD
HD
HD
recipient
recipient
recipient
recipient
staff
staff
staff
staff
..............................
..............................
..............................
..............................
CQM HD Recipient Interview Guide
TBC HD Recipient Interview Guide
MTM HD Recipient Interview Guide
CCL HD Recipient Interview Guide
25
13
12
25
Category B Case Study SHD-Level Group Discussion Guide
HD recipient staff ..............................
HD recipient staff ..............................
HD recipient staff ..............................
CQM HD Recipient Group Discussion Guide.
TBC HD Recipient Group Discussion Guide.
CCL HD Recipient Group Discussion Guide.
Category B Cost Study
HD recipient staff ..............................
Partner site staff ................................
HD Recipient Resource Use and
Cost Inventory Tool (Category B).
Partner Site-Level Resource Use
and Cost Inventory Tool (Category B).
Recipient-Led Evaluation Report Templates
HD recipient staff ..............................
HD recipient staff ..............................
HD recipient staff ..............................
Total ...........................................
Category A EPMP Template ............
Category A—DDT Recipient-led Annual Evaluation Report Template(s).
Category B—DHDSP Recipient-led
Evaluation Reporting Deliverable
Template(s).
51
51
1
1
8
8
136
408
51
1
8
408
...........................................................
1,792
........................
........................
2,303
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2019–14301 Filed 7–3–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–19–19BHM; Docket No. CDC–2019–
0056]
jbell on DSK3GLQ082PROD with NOTICES
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS)
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
SUMMARY:
VerDate Sep<11>2014
17:54 Jul 03, 2019
Jkt 247001
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled Understanding
important issues in Ovarian Cancer
Survivorship (OCS) project. The OCS
project aims to better understand the
needs of ovarian cancer survivors and
how to more effectively develop
interventions targeted to this
population.
Written comments must be
received on or before September 3,
2019.
DATES:
You may submit comments,
identified by Docket No. CDC–2019–
0056 by any of the following methods:
ADDRESSES:
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: All public comment
should be submitted through the
Federal eRulemaking portal
(regulations.gov) or by U.S. Mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
E:\FR\FM\05JYN1.SGM
05JYN1
]]>Agencies
[Federal Register Volume 84, Number 129 (Friday, July 5, 2019)]
[Notices]
[Pages 32185-32187]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-14301]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-19-19BHC; Docket No. CDC-19-0055]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled EVALUATION OF THE DP18-1815
COOPERATIVE AGREEMENT PROGRAM: IMPROVING THE HEALTH OF AMERICANS
THROUGH PREVENTION AND MANAGEMENT OF DIABETES AND HEART DISEASE AND
STROKE. The purpose of data collection is to determine CDC-funded
recipients' progress towards using DP18-1815 funds to implement
evidence-based strategies, and to determine how those efforts are
contributing to state level and health system level changes to support
prevention and management of diabetes and heart disease.
DATES: CDC must receive written comments on or before September 3,
2019.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2019-
0055 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
Evaluation of the DP18-1815 Cooperative Agreement Program:
Improving the Health of Americans Through Prevention and Management of
Diabetes and Heart Disease and Stroke--New--National Center for Chronic
Disease Prevention and Health Promotion, Centers for Disease Control
and Prevention (CDC).
[[Page 32186]]
Background and Brief Description
The Centers for Disease Control and Prevention (CDC) Division of
Diabetes Translation (DDT) and Division for Heart Disease and Stroke
Prevention (DHDSP) are submitting this new three year information
collection request (ICR) for an evaluation of the recently launched
five-year Cooperative Agreement program CDC-RFA-DP18-1815PPHF18:
Improving the Health of Americans Through Prevention and Management of
Diabetes and Heart Disease and Stroke, hereafter referred to as
``1815''. This cooperative agreement funds all 50 State Health
Departments and the Washington, DC health department (hereafter
referred to as ``HD recipients'') to support investments in
implementing evidence-based strategies to prevent and manage
cardiovascular disease (CVD) and diabetes in high-burden populations/
communities within each state and the District of Columbia. High burden
populations/communities are those affected disproportionately by high
blood pressure, high blood cholesterol, diabetes, or prediabetes due to
socioeconomic or other characteristics, including access to care, poor
quality of care, or low income. The 1815 program is a collaboration
between DDT and DHDSP and is structured into two program categories
aligning with each Division: Category A focuses on diabetes management
and Type 2 diabetes prevention; Category B focuses on CVD prevention
and management.
This cooperative agreement is a substantial investment of federal
funds. DDT and DHDSP are responsible for the stewardship of these
funds, and they must be able to demonstrate the types of interventions
being implemented and what is being accomplished through the use of
these funds. Thus, throughout the five-year cooperative agreement
period, CDC will work with HD recipients to track the implementation of
the cooperative agreement strategies and evaluate program processes and
outcomes. In order to collect this information, CDC has designed four
overarching components: (1) Category A rapid evaluation of DSMES and
National DPP partner sites, (2) Category B case studies, (3) Category B
cost study, and (4) Category A and B recipient-led evaluations. Each
component consists of data collection mechanisms and tools that are
designed to capture the most relevant information needed to inform the
evaluation effort while placing minimum burden on respondents.
Respondents will include HD recipients, as well as select HD recipient
partner sites, which are organizations that HD recipients are
partnering with in the implementation of the 1815 strategies.
The evaluation of cooperative agreement strategies and activities
conducted by DDT and DHDSP will determine the efficiency,
effectiveness, impact and sustainability of 1815-funded strategies in
the promotion, prevention, and management of diabetes and heart disease
and help identify promising practices that can be replicated and scaled
to better improve health outcomes. In addition, evaluation plays a
critical role in organizational learning, program planning, decision-
making, and measurement of the 1815 strategies. As an action-oriented
process, the evaluation will serve to identify programs that have
positive outcomes, identify those that may need additional technical
assistance support, and highlight the specific activities that make the
biggest contribution to improving diabetes and cardiovascular disease
prevention and management efforts. Without collection of new evaluative
data, CDC will not be able to capture critical information needed to
continuously improve programmatic efforts and clearly demonstrate the
use of federal funds.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of
Type of respondents Form name Number of responses per Average burden Total burden
respondents respondent per response (in hours)
----------------------------------------------------------------------------------------------------------------
Category A Site-Level Rapid Evaluation
----------------------------------------------------------------------------------------------------------------
HD recipient staff............ National DPP 51 1 30/60 8.5
Partner Site-
Level Rapid
Evaluation Site
Nomination Form.
HD recipient staff............ DSMES Partner 51 1 30/60 8.5
Site-Level
Rapid
Evaluation Site
Nomination Form.
DSMES partner site staff...... DSMES Rapid 14 1 2 28
Evaluation
Interview
Guide--Program/
Quality
Coordinator.
DSMES partner site staff...... DSMES Rapid 28 1 2 56
Evaluation
Interview
Guide--Paraprof
essional.
DSMES partner site staff...... DSMES Rapid 28 1 2 56
Evaluation
Interview
Guide--Health
Professional.
DSMES partner site staff...... DSMES Rapid 510 1 1 340
Evaluation
Survey
Questionnaire.
National DPP partner site National DPP 14 1 2 28
staff. Rapid
Evaluation
Interview
Guide--Program
Coordinator.
National DPP partner site National DPP 28 1 2 56
staff. Rapid
Evaluation
Interview
Guide--Lifestyl
e Coach.
National DPP partner site National DPP 510 1 1 340
staff. Rapid
Evaluation
Survey
Questionnaire.
----------------------------------------------------------------------------------------------------------------
Category B Case Study--Site-Level Interviews
----------------------------------------------------------------------------------------------------------------
Partner site staff............ CQM Partner Site- 45 1 1.5 22.5
Level Interview
Guide.
Partner site staff............ TBC Partner Site- 24 1 1.5 12
Level Interview
Guide.
Partner site staff............ MTM Partner Site- 21 1 1.5 10.5
Level Interview
Guide.
[[Page 32187]]
Partner site staff............ CCL Partner Site- 45 1 1.5 22.5
Level Interview
Guide.
----------------------------------------------------------------------------------------------------------------
Category B Case Study--SHD-Level Interview
----------------------------------------------------------------------------------------------------------------
HD recipient staff............ CQM HD Recipient 25 1 2 33.5
Interview Guide.
HD recipient staff............ TBC HD Recipient 13 1 2 17.5
Interview Guide.
HD recipient staff............ MTM HD Recipient 12 1 2 16
Interview Guide.
HD recipient staff............ CCL HD Recipient 25 1 2 33.5
Interview Guide.
----------------------------------------------------------------------------------------------------------------
Category B Case Study SHD-Level Group Discussion Guide
----------------------------------------------------------------------------------------------------------------
HD recipient staff............ CQM HD Recipient 40 1 2.5 67
Group
Discussion
Guide.
HD recipient staff............ TBC HD Recipient 40 1 2.5 67
Group
Discussion
Guide.
HD recipient staff............ CCL HD Recipient 40 1 2.5 67
Group
Discussion
Guide.
----------------------------------------------------------------------------------------------------------------
Category B Cost Study
----------------------------------------------------------------------------------------------------------------
HD recipient staff............ HD Recipient 25 1 2.5 21
Resource Use
and Cost
Inventory Tool
(Category B).
Partner site staff............ Partner Site- 50 1 2.5 42
Level Resource
Use and Cost
Inventory Tool
(Category B).
----------------------------------------------------------------------------------------------------------------
Recipient-Led Evaluation Report Templates
----------------------------------------------------------------------------------------------------------------
HD recipient staff............ Category A EPMP 51 1 8 136
Template.
HD recipient staff............ Category A--DDT 51 1 8 408
Recipient-led
Annual
Evaluation
Report
Template(s).
HD recipient staff............ Category B-- 51 1 8 408
DHDSP Recipient-
led Evaluation
Reporting
Deliverable
Template(s).
---------------------------------------------------------------
Total..................... ................ 1,792 .............. .............. 2,303
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019-14301 Filed 7-3-19; 8:45 am]
BILLING CODE 4163-18-P
